ESC 2026: The SINGLE-AF Study—Anticoagulation Even for Intermediate Stroke Risk?
This Medudy course is a video podcast for physicians on the SINGLE-AF study, which was presented as a hotline/late-breaking clinical trial at the 2026 ESC Congress in Munich and published simultaneously in the New England Journal of Medicine. Prof. Dr. Christian-Hendrik Heeger and Prof. Dr. Julian Chun discuss the first randomized study on direct oral anticoagulants (DOACs) in patients with […]
KEYNOTE-826 5-Year Overall Survival Data
This Medudy course is a video tutorial for physicians on current treatment options for persistent, recurrent, or metastatic cervical cancer. In this video, Prof. Dr. Annette Hasenburg, Director of the Department of Obstetrics and Women’s Health at Mainz University Medical Center, presents the long-term data from the KEYNOTE-826 study. The focus is on the 5-year data for pembrolizumab in […]
KEYNOTE-A18 Final OS Data and Patient Selection
This Medudy course is a video tutorial for physicians on current treatment options for locally advanced cervical cancer. In this video, Prof. Dr. Annette Hasenburg, Director of the Department of Obstetrics and Women’s Health at Mainz University Medical Center, presents the final survival data from the KEYNOTE-A18 study and discusses the role of pembrolizumab in combination with […]
New ESC Guidelines on Heart Failure—What Will Change in Clinical Practice?
This Medudy course is a conference report for physicians on the topic “New ESC Guidelines on Heart Failure—What Will Change in Clinical Practice?” Prof. Dr. Michael Böhm, a professor at the Homburg Institute for Cardiorenal Metabolic Medicine at Saarland University, will present the most important changes in the updated guidelines from the European Society of Cardiology (ESC) […]
ESC 2026: PIFPAF-PFA – Are We Measuring Ablation Success Incorrectly?
This Medudy course is a video podcast for physicians on the PIFPAF-PFA study, which was presented as a late-breaking clinical trial at the 2026 ESC Congress in Munich and published simultaneously in JAMA. Prof. Dr. Christian-Hendrik Heeger and Prof. Dr. Roland Tilz discuss the first randomized study on additional posterior wall isolation (PWI) as a supplement to pulmonary vein isolation (PVI) using pulsed-field ablation (PFA) in […]
ESC 2026: The First Guidelines on Cardiovascular and Kidney Diseases
This Medudy course is a video podcast for physicians on the 2026 ESC guidelines regarding cardiovascular diseases in chronic kidney disease. Prof. Dr. Michael Böhm and Prof. Dr. Norbert Frey explain why a systematic approach to the heart-kidney axis is becoming increasingly crucial for risk assessment, diagnosis, and treatment. The focus is on determining eGFR and albuminuria, as well as identifying […]
ESC 2026: The New Heart Failure Guidelines
with Prof. Dr. Michael Böhm and Prof. Dr. Holger Thiele This Medudy course is a video podcast for physicians on the clinically relevant updates to the 2026 ESC Guidelines on Heart Failure. Prof. Dr. Michael Böhm and Prof. Dr. Holger Thiele discuss the new classification of heart failure, the staging system from A to D, and the revised assessment […]
Glomerulonephritis: Prevalence, Classification, and Treatment
This Medudy course is a video tutorial for physicians on the topic of “Glomerulonephritis: Prevalence, Classification, and Treatment.” Prof. Dr. Jürgen Floege, a nephrologist and senior professor at the Department of Nephrology and Hypertension at Aachen University Hospital, provides a general overview of glomerulonephritis in this video, which is part of a video series focusing on C3 glomerulopathy (C3G). He […]
PNH in Everyday Clinical Practice
This Medudy course is a video tutorial for physicians on the topic of “PNH in Everyday Clinical Practice.” In this video, Dr. Jörg Chromik, senior physician and director of the Outpatient Clinic for Hematology and Oncology at Frankfurt University Hospital, discusses paroxysmal nocturnal hemoglobinuria (PNH) and its significance in everyday clinical practice. In this first video of a series […]
The Urothelial Carcinoma Cohort of the Destiny-PanTumor02 Trial: Efficacy and Safety of Trastuzumab Deruxtecan in Patients with Metastatic HER2-Expressing (IHC 3+) Solid Tumors
This Medudy course is a video tutorial for physicians on the topic “The Urothelial Carcinoma Cohort of the Destiny-PanTumor02 Trial: Efficacy and Safety of Trastuzumab Deruxtecan in Patients with Metastatic HER2-Expressing (IHC 3+) Solid Tumors.” Dr. Niklas Klümper, a senior physician in urology at the University Hospital of Bonn specializing in medical tumor therapy, summarizes the key findings of the […] in this video.